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MarylandABSTRACT The mechanism by which glucose induces insulin secretion in b-cells is fairly well understood. Despite years of
research, however, the mechanism of glucagon secretion in a-cells is still not well established. It has been proposed that glucose
regulates glucagon secretion by decreasing the conductance of either outward ATP-dependent potassium channels (K(ATP)) or
an inward store-operated current (SOC). We have developed a mathematical model based on mouse data to test these hypoth-
eses and found that both mechanisms are possible. Glucose metabolism closes K(ATP) channels, which depolarizes the cell but
paradoxically reduces calcium influx by inactivating voltage-dependent calcium and sodium channels and decreases secretion.
Glucose metabolism also activates SERCA pumps, which fills the endoplasmic reticulum and hyperpolarizes the cells by
reducing the inward current through SOC channels and again suppresses glucagon secretion. We find further that the twomech-
anisms can combine to account for the nonmonotonic dependence of secretion on glucose observed in some studies, an effect
that cannot be obtained with either mechanism alone.INTRODUCTIONGlucose homeostasis is largely controlled by a- and b-cells
located in pancreatic islets. Both cell types respond to blood
glucose levels, albeit in an opposite manner. Whereas
b-cells secrete insulin when blood glucose is elevated,
a-cells secrete glucagon when blood glucose levels are
low. The mechanism by which glucose induces insulin
secretion in b-cells is fairly well understood. Glucose enters
the cell through GLUT2 transporters, which causes an in-
crease in the ATP/ADP ratio. This causes the ATP-sensitive
Kþ (K(ATP)) channels to close, depolarizing the cell and al-
lowing Ca2þ to enter through voltage-gated Ca2þ channels.
This influx of Ca2þ triggers insulin secretion (1). Surpris-
ingly, a-cells share much of the same secretory machinery
as b-cells, including glucose transporters, voltage-gated
Ca2þ channels, and K(ATP) channels. However, despite
years of research, the mechanism of glucagon secretion is
still not well understood (2).
There is an ongoing debate as to whether glucose sup-
presses glucagon secretion directly through an intrinsic
mechanism, within the a-cell, or indirectly through an
extrinsic mechanism (3). Although there is evidence that
glucagon secretion is suppressed by paracrine effects such
as insulin (4,5), Znþ (6,7), g-amino butyric acid (8–10),
and somatostatin (11–13), glucagon secretion in mice is
maximally suppressed at glucose concentrations that are
too low to stimulate insulin or somatostatin release (3,14).
It has also been shown that paracrine regulators do not
inhibit secretion below the basal rate (2). These facts point
to a role for intrinsic regulation of glucagon secretion forSubmitted August 19, 2013, and accepted for publication November 26,
2013.
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0006-3495/14/02/0741/11 $2.00low glucose concentrations (<6 or 7 mM) in mouse, but
in humans the case is not so clear (3). Interspecies differ-
ences could account for some of the variation in data in
the literature.
There are two theories for how glucose can intrinsically
regulate glucagon secretion in the a-cell. One theory is that
glucose affects the a-cell through closure of K(ATP) chan-
nels (15–17). As in b-cells, after glucose enters the cell,
the ATP/ADP ratio would increase, leading to the closure
of K(ATP) channels and cell depolarization. However, unlike
b-cells, this depolarization has been proposed to decrease
glucagon secretion. An alternative theory, which does not
depend on K(ATP) channels, proposes that glucose regulates
glucagon secretion through a store-operated current (SOC)
(18,19). Glucose could regulate secretion through SOC by
providing additional ATP to activate sarcoendoplasmic retic-
ulum calcium transport ATPase (SERCA), which pumps and
fill the Ca2þ stores. When glucose is high, the stores would
fill, turning off SOC. The loss of current would reduce spike
activity and decrease secretion. When glucose is low, Ca2þ
stores would empty, turning on SOC and increasing spike ac-
tivity and glucagon secretion.
In this article, we investigate how glucose can intrinsically
regulate glucagon secretion by incorporating the effects of
glucose on K(ATP) conductance (gK(ATP)) and SOC (gSOC)
into a mathematical model for a-cell electrical activity and
Ca2þ handling. We show that, depending upon the parame-
ters of the cell, glucose can suppress glucagon secretion
through eithermechanism.We find further that the twomech-
anisms can combine to account for the nonmonotonic depen-
dence of secretion on glucose observed in some studies, an
effect that cannot be obtained with either mechanism alone.
The model is mostly based on data from mouse, but we
believe the basic principles would apply to humans becausehttp://dx.doi.org/10.1016/j.bpj.2013.11.4504
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results depend on quantitative relationships among parame-
ters that differ in humans and mice, and they may not hold
in humans even if they are correct for mice.MATERIALS AND METHODS
Model
The model presented here is modified from a model of electrical activity
in mouse a-cells (20). We add equations for cytosolic Ca2þ, endoplasmic
reticulum (ER) Ca2þ, and secretion. We also modified parameters of the
ionic currents to reduce spike frequency near threshold and increase
spike amplitude, in better agreement with experimental data. In this sec-
tion, we introduce the main features of the model. Equations and param-
eters not described here can be found in the Appendix, found in the
Supporting Material. The original parameters from Diderichsen and
Go¨pel (20) have been included in Table S1 and Table S2 in the Support-
ing Material for comparison. The equation for the plasma membrane po-
tential (V) is
dV
dt
¼ ICaL þ ICaN þ ICaT þ INa þ IK þ IKðATPÞ
þ IKA þ IL þ ISOC

Cm;
(1)
where Cm is the membrane capacitance; ICaL, ICaN, and ICaT are L-, N-, and
T-type voltage-dependent Ca2þ currents, respectively; INa is a voltage-
dependent Naþ current; IK is a delayed rectifier K
þ current; IKA is an
A-type voltage-dependent Kþ current; IK(ATP) is an ATP-sensitive K
þ cur-
rent; IL is a leak current; and ISOC is a store-operated Ca
2þ current.
The equation for IK(ATP) is
IKðATPÞ ¼ gKðATPÞðV  VKÞ; (2)
where gK(ATP) is the K(ATP) channel conductance. To focus on the electrical
properties of a-cells in this study, we do not consider glucose metabolism or
the dependence of gK(ATP) on the ATP/ADP ratio, but simply treat gK(ATP) as
a parameter that can be decreased to represent an increase in glucose or
addition of a blocker, such as tolbutamide. The equation for ISOC is
ISOC ¼ gsoccerNðV  VSOCÞ; (3)
where gSOC is the maximal conductance of the store-operated current, VK
and VSOC are reversal potentials, and cerN represents Cer-dependent activa-
tion, given by
cerNðCerÞ ¼ 1
1þ expððCer  cerÞ=20Þ: (4)
Thus, the amount of calcium in the ER determines the amount of SOC cur-
rent. Glucose can affect both IK(ATP) and ISOC. Glucose metabolism in-
creases the ATP/ADP ratio, which decreases gK(ATP). Glucose metabolism
also fills the stores by activating SERCA pumps, which decreases the
conductance of the SOC current, gSOC, where
gSOC ¼ gSOC cerNðCerÞ: (5)
For glucose that is high enough, ISOCz 0.
In the absence of data on SOC in a-cells, we have modeled it as a nonse-
lective cation current that carries Naþ but not much Ca2þ, as reported in
b-cells (21,22).
The original Diderichsen model did not include N-type Ca2þ channels,
the SOC, Ca2þ dynamics, or glucagon secretion. Therefore, equationsBiophysical Journal 106(3) 741–751were added for bulk intracellular Ca2þ (Ci), Ca
2þ in the endoplasmic retic-
ulum (Cer), Ca
2þ in a microdomain surrounding L- and N-type Ca2þ chan-
nels (CmdL, CmdN), and glucagon secretion.
Although Ca2þ enters mainly through L-type channels (18,23), N-type
(15,16,24–26) and P/Q-type (27,28) channels have been suggested to be
more important for glucagon secretion. We modeled glucagon secretion
as depending on Ca2þ in the microdomains surrounding N-type Ca2þ chan-
nels, but our results would not change much if we had used P/Q channels
because the main requirement is a high threshold for voltage activation.
The rate of secretion is expressed as
JGS ¼ NN mCaN hCaN

CmdN
kN þ CmdN
4
; (6)
following the formulation in Pedersen and Sherman (29).
The total amount of glucagon secreted can be evaluated as
MG ¼
Z t
0
JGSdt
0: (7)
The average glucagon secretion rate (GSR) plotted in the figures is calcu-
lated with an integral like that above, but with a 15-s moving time
window.
The differential equations were solved numerically with the variable step
size method CVODE implemented in the XPPAUT software package (30)
with absolute and relative tolerances 1010.RESULTS
Suppression of glucagon secretion through
K(ATP) channels
The model produces action potentials (APs) with low fre-
quency (~3 Hz) consistent with the experimental data ob-
tained in low glucose (Fig. 1 A). The development of the
individual currents during a single AP (Fig. 1 B) is shown
in Fig. 1 C. T-type Ca2þ channels (not shown) are involved
in the pacemaking of the APs. They open during the inter-
spike interval before the onset of an AP. As the voltage
slowly starts to rise, L-type channels begin to open. Then,
the Naþ current, INa (solid curve), activates causing the up-
stroke in the AP. After the membrane potential rises suffi-
ciently, the L-type Ca2þ channel opens further along with
N-type Ca2þ channels. ICaL and ICaN (shaded and dashed
shaded curves, respectively) also contribute to the upstroke
of the AP. Then the Naþ current inactivates, and the delayed
rectifier current, IK (dashed darker curve), turns on, which
together repolarize the cell. Like the T-type Ca2þ current,
the A-type Kþ current, IKA (not shown) also affects the in-
terspike interval. The second bump in INa is due to Na
þ
channels de-inactivating and was also seen in the original
Diderichsen model.
To determine if K(ATP) channels or SOC can reduce
glucagon secretion with the addition of glucose, we consider
each mechanism separately. To begin, suppression of secre-
tion by K(ATP) channels is explored by suppressing the
dependence of SOC on Cer and setting the conductance of
the SOC current (gSOC) to a constant (0.2 nS). With gSOC
FIGURE 2 Glucose can suppress glucagon secretion by reducing gK(ATP)
(gSOC¼ 0.2 nS). (A) If we assume that gK(ATP)¼ 0.32 nS in low glucose, the
cell spikes and glucagon is secreted (solid circle in Fig. 3 C). Increasing
glucose reduces gK(ATP), here set to 0.265 nS, reducing spike amplitude
and Ca2þ entry. This decreases Ci (B), Ca
2þ in the N-channel microdomains
(not shown) and glucagon secretion (C, blue circle in Fig. 3 C).
FIGURE 1 Electrical activity produced with the model. (A) Simulated
a-cell spiking with the model in low glucose (gK(ATP) ¼ 0.295 nS
and gSOC ¼ 0 nS). (B and C) Simulated currents during a single
action potential. INa triggers the sharp upstroke, leading to the activa-
tion of ICaL and ICaN. IK repolarizes the cell. To see this figure in color,
go online.
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the SOC current (Eq. 5) becomes
ISOC ¼ gSOCðV  VSOCÞ: (8)
It has been shown experimentally that adding glucose to a
spiking a-cell can cause the cell to depolarize and produce
spikes of reduced amplitude (15). These experiments are
modeled by reducing gK(ATP) (Fig. 2). In the absence of
glucose we assume that gK(ATP) ¼ 0.32 nS, and at this value
the model cell spikes (Fig. 2 A). The large spikes bring in
Ca2þ, raising Ci (Fig. 2 B) and increasing GSR (Fig. 2 C).
We model the increase of glucose as a decrease in gK(ATP)
(reduced ~17%, in line with Gromada et al. (15), to
0.265 nS). Now the cell produces spikes with a reduced
amplitude, which reduces Ci and microdomain Ca
2þ,
CmdN (not shown), due to inactivation of Ca
2þ channels.
As a consequence, glucagon secretion is reduced. When
glucose is removed, the system reverts to the original
large-amplitude spiking. Note that even though the reduc-
tion in amplitude is slight, there is a large effect on glucagon
secretion.
By treating gK(ATP) as a parameter, we can construct a
bifurcation diagram to show the behavior of the system as
gK(ATP) is varied (Fig. 3 A). The solid curve represents the
stable stationary solutions, and the dashed part the unstable
solutions. As gK(ATP) is increased past a lower threshold,
periodic solutions representing APs emerge (solid circles);
the minimum and maximum voltages are plotted as anindication of the amplitude. The threshold is mediated by
a Hopf bifurcation (see Rinzel and Ermentrout (31) for a
tutorial). This branch of solutions terminates at an upper
threshold, mediated by a saddle node of periodic orbits
(SNP), which is the point where the periodic branch from
the left Hopf bifurcation intersects a branch of unstable pe-
riodic solutions (open circles) arising from a second Hopf
bifurcation on the right. When gK(ATP) lies to the right of
the SNP (i.e., is >~0.4 nS), the cell is hyperpolarized and
silent.
We need not be concerned with the underlying mathe-
matics but can just take the bifurcation diagram as a sum-
mary of the repertoire of cell behaviors. Starting on the
right, as gK(ATP) is decreased, large-amplitude APs are pro-
duced, whereas further decreases in gK(ATP) decrease the
amplitude because of inactivation of Naþ and Ca2þ chan-
nels. There is also a small range of gK(ATP) values where
the cell produces small-amplitude, depolarized spikes.
For gK(ATP) between ~0.18 and 0.26 nS, no stable steady
states or periodic solutions are indicated in Fig. 3. In this re-
gion, patterns that are more complex are seen, such as spike
doublets and a form of bursting. For simplicity, we have not
labeled these and consider only ordinary spiking.
The electrical activity of the cell determines the amount
of glucagon that is secreted. Fig. 3 B shows how changing
gK(ATP) affects the amount of Ca
2þ in the microdomain.Biophysical Journal 106(3) 741–751
FIGURE 3 Bifurcation analysis of the model to investigate the role of
gK(ATP). (A) Bifurcation diagram of the model with gK(ATP) as the bifurca-
tion parameter (gSOC ¼ 0.2 nS). (Solid curve) Stable steady states; (solid
circles) stable spiking solutions. Maximum and minimum voltages of the
spike are plotted. (Dashed curve) Unstable steady states; (open circles)
unstable periodic solutions. (Green squares) Hopf bifurcations; (red
squares) saddle node of periodic bifurcations. (B) CmdN first increases
and then decreases as gK(ATP) decreases. (C) As gK(ATP) decreases, glucagon
secretion rate (GSR) first increases, then decreases as a result of changes in
spike frequency and CmdN. (Circles) Low glucose (red) and high glucose
(blue) conditions in Fig. 2, demonstrating that glucose can decrease
glucagon secretion by decreasing gK(ATP). To see this figure in color, go
online.
744 Watts and ShermanFig. 3 C shows that as gK(ATP) decreases, the glucagon secre-
tion rate (GSR) first increases and then decreases, producing
a bell-shaped curve. Glucagon secretion depends on two
features of the spikes, frequency and amplitude. GSR first
increases as gK(ATP) decreases because the frequency in-
creases, but then it decreases because amplitude decreases.
Even a modest decrease in spike height leads to a significant
decrease in secretion because the high-voltage activated
N-type Ca2þ channels close, reducing Ca2þ in their micro-
domains. In Fig. 2, we showed that glucose reduced secre-
tion by reducing spike amplitude. The bifurcation diagram
in Fig. 3 predicts that a deeper reduction of gK(ATP) would
produce smaller-amplitude spikes and a greater reduction
in secretion. This corresponds to the behavior seen experi-
mentally with the addition of tolbutamide (3,32). The results
also agree with the relationship between glucagon secretion
and K(ATP) channel activity seen in experiments using di-
azoxide (Dz) to titrate K(ATP) channel activity (3,16,17,33).
If we choose the solid circle (Fig. 3 C) to represent low
glucose, and the shaded circle to represent high glucose,
then glucose suppresses glucagon secretion at the sameBiophysical Journal 106(3) 741–751time that it depolarizes the cell. These correspond to the
low and high glucose conditions in Fig. 2. However, we
emphasize that, depending on the K(ATP) channel conduc-
tance at a particular glucose level, increasing glucose con-
centration could either increase or decrease glucagon
secretion. Thus, we have shown that glucose can regulate
glucagon secretion appropriately through its effect on
gK(ATP), but that this is not guaranteed to work.Suppression of glucagon secretion through a
store-operated current
Next, we investigate suppression of glucagon secretion by
an SOC, as suggested by the experiments in Liu et al. (18)
and Vieira et al. (19). Store-operated current (SOC) is an in-
ward current that decreases as ER Ca2þ increases, with
conductance described by Eq. 5. Following Liu et al. (18)
and Vieira et al. (19), we propose that in low glucose the
store is relatively depleted because of limited SERCA acti-
vation, and the a-cell spikes. Increasing glucose activates
SERCA and fills the ER, which turns off SOC and reduces
secretion.
To investigate whether SOC can regulate glucagon secre-
tion independently of K(ATP) channel activity, we fixed
gK(ATP). In the absence of information about the relationship
between glucose and SERCA activity in a-cells, we investi-
gated the effects of changing kSERCA (Fig. 4 D) on spiking
and secretion through its effects on gSOC. The value gSOC
was assumed to vary between 0 and 0.1 nS as Cer varies, a
range sufficient to produce significant changes in spike
activity.
Fig. 4 demonstrates regulation of glucagon secretion by
this mechanism. In low glucose, the ER is depleted (Fig. 4
C), and gSOC is ~0.075 nS (Fig. 4 E). Spiking drives Ca
2þ
entry, and glucagon is secreted (Fig. 4, A, B, and F). After
increasing glucose, Cer increases, and gSOC is reduced.
The loss of current hyperpolarizes the cell, which suppresses
Ca2þ entry and glucagon secretion. Note that Cer increases
in this simulation because kSERCA increases (Fig. 4 D),
despite the reduction of Ci due to the loss of spiking. It
was shown in Tengholm et al. (34) that the ER can fill
even when cytosolic Ca2þ is low, provided sufficient ATP
is present.
As we did for K(ATP) channels, we use a bifurcation di-
agram to examine the behavior of the system as a function of
gSOC (Fig. 5 A). The dependence of gSOC on Cer and kSERCA
is not relevant for understanding the effect of SOC on mem-
brane potential and CmdN, so ISOC is given by Eq. 8 as in
Fig. 3, but now gK(ATP) is held fixed and gSOC is varied.
This diagram is roughly a mirror image of the one for
gK(ATP) because SOC is an inward current. As gSOC de-
creases, corresponding to increased glucose, the system
goes from a depolarized steady state to small-amplitude
APs to large-amplitude spikes to a low-voltage steady state,
and CmdN increases, then decreases. As for gK(ATP), GSR is
FIGURE 4 Glucose can suppress glucagon secretion by reducing gSOC.
(A) In the absence of glucose, gK(ATP) is set to 0.31 nS and kSERCA to
0.1 ms1, resulting in gSOC z 0.075 nS. The cell spikes and glucagon is
secreted (solid circle in Fig. 5 B). Adding glucose hyperpolarizes the
cell, which reduces Ci (B). Despite the reduction in Ci, the ER fills (C)
because of the increase in kSERCA (D). The changes in V and Ci (E) are
driven by the reduction in gSOC. (F) The hyperpolarization of V reduces
CmdN (not shown), which is responsible for the reduction in glucagon secre-
tion (blue circle in Fig. 5 B).
FIGURE 5 Bifurcation analysis of the model to investigate the role of
SOC. (A) Bifurcation diagram of the model with gSOC as the bifurcation
parameter and gK(ATP) fixed at 0.31 nS. (Green squares) Hopf bifurcations;
(red squares) saddle node of periodic bifurcations. (B) CmdN increases and
then decreases as gSOC decreases. (C) GSR as a function of gSOC. As gSOC
increases, the GSR first increases then decreases. (Circles) Low glucose
(red) and high glucose (blue) conditions in Fig. 4, demonstrating that
glucose can decrease glucagon secretion by decreasing gSOC. To see this
figure in color, go online.
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and again results in a bell-shaped curve. Thus, glucose can
either increase or decrease glucagon secretion, depending
on the level of gSOC that corresponds to low glucose. The
solid circle (Fig. 5 C) represents the low glucose condition
in Fig. 4, whereas the shaded circle represents the high
glucose condition. With these choices, increasing glucose
decreases GSR.Nonmonotonic glucose dose-response curve
Although it is possible to reduce glucagon secretion by
either the K(ATP) channel or the SOC mechanism, it has
been reported that glucagon secretion is maximally in-
hibited around 7 mM glucose (G), then increases as glucose
levels rise further (3,14,19). Within the framework of our
model, this J-shaped dose-response curve, with paradoxical
stimulation of glucagon secretion at high glucose, cannot be
modeled by changes in gK(ATP) or gSOC alone. From Figs. 3
C and 5 C it can be seen that an increase in glucose will
cause either a monotonic decrease in secretion or an in-
crease followed by a decrease, depending on which point
on the bell-shaped curve corresponds to low glucose.
Although neither of these mechanisms alone can producea decrease in secretion followed by an increase, we show
in Fig. 6 that this result can be obtained by combining the
effects of gK(ATP) and SOC.
Fig. 6 A is a two-parameter bifurcation diagram for the
model, with gK(ATP) and gSOC as the bifurcation parameters.
It shows how the key bifurcations, with respect to gK(ATP) in
Fig. 3 A, shift as gSOC is varied. The left and right Hopf bi-
furcations (solid curves HBL and HBR), where the steady
state gives way to spiking, slant up and to the right because
more inhibition from gK(ATP) is needed to balance the
increased inward SOC current. The shaded curve of SNPs,
which marks the upper limit of spiking as gK(ATP) is
increased, also generally slants to the right. We assume
that increasing glucose will decrease both gK(ATP) and
gSOC as it blocks K(ATP) channels and increases SERCA
activity, indicated by the arrow slanting down and to the
left. If we further assume that SERCA activation is more
sensitive to glucose metabolism than K(ATP) conductance,
then gSOC would decrease before gK(ATP) decreases. This
implies a trajectory like the dashed curve. (See the Discus-
sion for more on this point.)
Taking the parameters from the dashed curve (Fig. 6 A)
produces a J-shaped glucose dose-response curve (Fig. 6
B), where the shaded circle represents low glucose, the solidBiophysical Journal 106(3) 741–751
FIGURE 6 The model is able to produce a J-shaped glucose dose-
response curve by combining the effects of gK(ATP) and SOC. (A) Two-
parameter bifurcation diagram with gK(ATP) and gSOC as the bifurcation
parameters. If we assume that as glucose decreases, the phase point (dashed
line) travels down (arrow), the model produces the dose-response curve in
panel B. If the cell moves as shown (red circle to the blue circle), GSR
decreases, mainly because of decreased gSOC. As the cell moves from the
blue circle to the green circle, GSR rises, mainly because of decreased
gK(ATP). To see this figure in color, go online.
FIGURE 7 Bifurcation analysis reproducing the glucose dose-response
curve. Bifurcation diagrams (brown) and glucagon secretion rate curves
(black) are plotted for different values of gSOC. (A) As gSOC decreases,
the bifurcation diagram moves to the left. Therefore, if low glucose condi-
tions place the parameters as shown (red circle, gSOC ¼ 0.07), adding
glucose will decrease gSOC and gK(ATP). The net effect is a decrease in secre-
tion (blue circle, gSOC ¼ 0.01). (B) If we now add more glucose to the sys-
tem, gSOC still decreases (but not as much), so the effect on the bifurcation
diagram is reduced. Now, the net effect is an increase in secretion (green
circle, gSOC ¼ 0.005) because decreasing gK(ATP) moves the cell up the
GSR curve. To see this figure in color, go online.
746 Watts and Shermancircle represents intermediate glucose, and the open circle
represents high glucose. In this scenario, the decrease in
secretion from low to intermediate glucose results mainly
from decreased SOC conductance, and the increase in secre-
tion from intermediate to high glucose results mainly from
decreased K(ATP) conductance.
An alternative view of how the J-shaped dose-response
curve comes about is shown in Fig. 7, where instead of a
two-parameter bifurcation diagram, we show how the one-
parameter bifurcation diagrams with respect to gK(ATP)
(shaded curves) shift as gSOC changes. The solid curves
are the corresponding glucagon secretion rates. In low
glucose, gSOC and gK(ATP) are at their highest levels (right-
most curves, gSOC ¼ 0.07). Increasing glucose decreases
gSOC and gK(ATP) (leftmost curves, gSOC ¼ 0.01). The
decrease in gSOC causes the bifurcation diagram and the
GSR curve to shift to the left (Fig. 7 A). Thus, despite
the reduction in gK(ATP), which by itself would have
increased GSR, the decrease in gSOC dominates and results
in a decrease in GSR (the cell moves from the shaded to the
solid circle).
A further increase in glucose has little effect on gSOC,
because SERCA is assumed to be saturated, and hence has
little effect on the bifurcation diagram and GSR curveBiophysical Journal 106(3) 741–751(Fig. 7 B). The main effect is the decrease in gK(ATP), which
increases secretion (the cell moves from the solid to the
open circle (gSOC ¼ 0.005), climbing up the GSR curve).
The conclusion that the initial decrease in secretion is due
to a reduction in SOC, while the increase at higher glucose
can be attributed to changes in gK(ATP), is supported by
experimental data in Vieira et al. (19). That study reported
that activation of SOC by blocking the SERCA pump with
cyclopiazonic acid (CPA) increases glucagon secretion
and prevents the inhibitory effect of glucose.
The model can reproduce the main features of those ex-
periments, as shown in Fig. 8, which replots the glucose
dose-response curve from Fig. 6 B (solid) along with the
glucose dose-response curve with CPA added (dashed).
The addition of CPA was modeled by fixing gSOC at
0.08 nS. As in the experiments, glucagon secretion is higher
for all glucose levels in the presence of CPA, and the inhib-
itory effect of glucose has been lost.
Another recent article (35) demonstrates that glucose
(G) and tolbutamide (Tolb) exert distinct effects on
glucagon secretion. In fact, it was argued that there exists
an unknown mechanism that contributes to glucose suppres-
sion of glucagon secretion other than K(ATP) channels and
paracrine factors. We propose that the unknown mechanism
is, at least in part, SOC.
One particular experiment in Cheng-Xue et al. (35)
showed an inhibitory effect of Tolb in 1 mM (G), but a stim-
ulatory effect in 7 mMG. The model can reproduce this data
if we make certain assumptions about the SOC and K(ATP)
conductances. We assume that SOC is on in low glucose,
nominally 1 mM (Fig. 9, A–C). We further assume that
the cell sits near the peak of the GSR curve. In this scenario,
FIGURE 8 Effects of the SERCA inhibitor cyclopiazonic acid (CPA) on
glucagon secretion. In the presence of CPA, gSOC is set to 0.08 nS.
Glucagon section is higher and the inhibitory effect of glucose has been
lost (dashed curve). The glucose dose-response curve from Fig. 7 B (solid
curve) is plotted for comparison.
FIGURE 9 Effect of tolbutamide (Tolb) and diazoxide (Dz) for two
different levels of glucose. (A–C) In low glucose, we assume kSERCA ¼
0.05 ms1, making gSOC ¼ 0.1 nS during the simulation. Reducing gK(ATP)
with tolbutamide (Tolb) reduces Ca2þ entry and secretion is reduced. Open-
ing K(ATP) channels with Dz increases gK(ATP) and decreases secretion.
(D–F) In the presence of glucose, we assume kSERCA ¼ 0.3 ms1, making
gSOC ¼ 0 nS during the simulation. The addition of Tolb heightens secre-
tion, whereas the addition of Dz decreases it.
Suppression of Glucagon Secretion 747the addition of tolbutamide would cause a reversible
decrease in gK(ATP) and a reduction in secretion. The addi-
tion of Dz, which increases gK(ATP), would also reduce
secretion.
However, in intermediate glucose, nominally 7 mM, SOC
would be off because glucose would fill the ER, and gK(ATP)
would be lower (Fig. 9, D–F). The net result would be a
glucagon secretion rate lower than at 1 mM G (Fig. 9 D).
Now the addition of Tolb increases secretion, whereas Dz
still inhibits secretion. For the simulations in Fig. 9, the
change in glucose concentrations modeled by a change in
kSERCA and gK(ATP), whereas the addition of tolbutamide
only affects gK(ATP).
Fig. 10 shows the glucagon secretion rate curves corre-
sponding to the simulations in Fig. 9 for low glucose (gSOC¼
0.1 nS; dashed curve) and intermediate glucose (gSOC ¼ 0;
solid curve). In low glucose, the GSR curve lies to the right
of the GSR curve in intermediate glucose because of the
stimulus provided by SOC. In Fig. 9, A–C, gK(ATP) was cho-
sen such that secretion was almost maximal (open shaded
circle), so addition of Tolb decreased secretion (open cir-
cle). In Fig. 9, D–F, in contrast, we assumed that gK(ATP),
while reduced, lay to the right of the maximum (solid
shaded circle), so decreasing gK(ATP) with Tolb, increased
secretion (solid circle).
Of course, if the decrease in gK(ATP) due to increased
glucose had been great enough, Tolb would have decreased
secretion. Nonetheless, there is a wide range of possible
gK(ATP) values that would result in an increase. Conduc-
tances were not measured in Cheng-Xue et al. (35), so wecan only say that the mechanism is plausible, not that it is
proven. A further caveat is that the model does not yet
address paracrine effects, which may also have contributed
in the experiments.DISCUSSION
We have described a mathematical model of the pancreatic
a-cell and used it to demonstrate two separate mechanisms
for intrinsic regulation of glucagon secretion. The first
mechanism demonstrated was suppression of glucagon
secretion by closure of K(ATP) channels (Fig. 2). This sce-
nario assumes that glucose raises the ATP/ADP ratio. It is
also necessary to assume that the prevailing K(ATP) channel
conductance in low glucose lies near the maximum of the
curve of glucagon secretion versus gK(ATP) (Fig. 3). Then,
the depolarization due to reduced gK(ATP) would reduce
spike amplitude, decrease Ca2þ influx through N-type
Ca2þ channels and reduce glucagon secretion.
The effect of glucose on the ATP/ADP ratio in a-cells is
uncertain. Some studies report no change (23,36), but others
show an increase in ATP with glucose (6,37,38). We have
sidestepped this by simulating the effect of changes in
K(ATP) conductance rather than changes in ATP/ADP.
Even if glucose does close K(ATP) channels in a-cells, secre-
tion might not be inhibited. Some studies have shown thatBiophysical Journal 106(3) 741–751
FIGURE 10 GSRs for the simulations in Fig. 9. In low glucose condi-
tions (dashed curve), before Tolb was added, the parameters were as shown
(open red circle), and glucagon secretion was near maximal. After Tolb was
added, gK(ATP) decreased (open blue circle), and the glucagon secretion rate
decreased. In intermediate glucose (solid curve), before Tolb was added
(solid red circle) the parameters sat to the right of the maximal secretion
point. Therefore when Tolb was added, secretion increased (solid blue
circle). Note that the decrement in gK(ATP) assumed for Tolb was the
same for both cases; only the position on the GSR curve differed. To see
this figure in color, go online.
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(6,39–41). Indeed, as we have emphasized, the model indi-
cates that the effect of K(ATP) channel closure depends on
the position of gK(ATP) along the GSR curve. Although the
model may seem to be maddeningly inconclusive, we believe
that it in fact reflects faithfully the maddeningly inconclusive
data and is the only way to make sense of that data.
There is no getting around the fact that a-cells are
extremely heterogeneous (42–44), and the bell-shaped
GSR curves imply that quantitative variation can change
the direction of an effect. The studies reporting that glucose
stimulates glucagon secretion (6,39–41) have been used to
argue that glucagon secretion is suppressed by paracrine,
rather than intrinsic, factors. We return to this point at the
end and posit a deep connection between heterogeneity
and paracrine effects.
To make matters more complicated, we have shown that
glucose can also suppress glucagon secretion by reducing
an SOC (Fig. 4). This scenario assumes that the SOC and
K(ATP) conductances in low glucose place the cell near
the maximum of the GSR curve (Fig. 5). It further assumes
that increased glucose metabolism activates SERCA pumps.
Given this, glucose would fill the ER, reduce gSOC, and hy-
perpolarize the cells. A recent article (35) suggests that
something other than paracrine factors or K(ATP) channels
is needed to explain the suppression of glucagon secretionBiophysical Journal 106(3) 741–751by glucose. The model shows that SOC is well suited to
fill this gap and is supported by data showing loss of sup-
pression when the SERCA pump is blocked by CPA (19),
an effect that can be simulated by the model (Fig. 8). We
know even less about the effect of glucose on SOC than
on K(ATP); indeed there is no direct electrophysiological
evidence for the existence of SOC current in a-cells. We
have sidestepped this by simulating the effects of changes
in SERCA pump activity rather than glucose, but even this
depends on unknown relationships among SERCA, ER
Ca2þ, and SOC conductance. The surest thing we can say
is that the two-parameter bifurcation diagram (Fig. 6 A) im-
plies a constraint: the larger the K(ATP) conductance, the
larger the SOC (or other inward) conductance needed to
counterbalance it.
The electrical effects of the two mechanisms are opposite:
K(ATP) depolarizes the cell and SOC hyperpolarizes it.
That both depolarization and hyperpolarization can reduce
secretion is a consequence of the bell-shaped GSR curves.
For the same reason, they can both increase secretion.
Experimentally it has been reported both that glucose depo-
larizes a-cells (7,15,17) and that it hyperpolarizes them
(25,45). We propose that both K(ATP) channels and SOC
are present and affect glucagon secretion in the a-cell, but
the direction of the effect is determined by where a given
cell sits on the GSR curves generated by the two conduc-
tances. Again, heterogeneity is key.
The most appealing model is one in which SOC and
K(ATP) work together. Of the mechanisms we have consid-
ered, this combination, and only this combination, can ac-
count (Figs. 6–8) for the J-shaped secretion dose-response
curve observed experimentally (3,14,19). In this scenario
the reduction as glucose concentration is increased from,
say, 1 to 7 mM is due to SOC and the paradoxical rise at
higher glucose is due to K(ATP). It has been argued
(41,46) that the increase in glucagon secretion at high
glucose operates through a non-Ca2þ-dependent pathway,
possibly increased granule mobilization, analogous to the
amplification effect on insulin exocytosis in b-cells (1). Sup-
porting this hypothesis, in Salehi et al. (14) an increase in
glucose from 7 to 30 mM in the presence of diazoxide
increased glucagon secretion in the absence of any change
in Ca2þ concentration. This does not, however, rule out an
increase also in Ca2þ concentration when Ca2þ is not
clamped. Such an increase is shown in LeMarchand and Pis-
ton (41), and, unless Ca2þ is elevated at high glucose, there
would not be much secretion for metabolism to amplify. The
combination of SOC and K(ATP) assumed in Fig. 6 can also
explain (Figs. 9 and 10) the opposite reactions to tolbuta-
mide in 1 and 7 mM G reported in Cheng-Xue et al. (35).
The assumption that SERCA saturates at a lower glucose
concentration than K(ATP) conductance is suggested by
data from b-cells showing that the ER Ca2þ saturates at
8 mM glucose (47), whereas K(ATP) conductance continues
to decrease as glucose is raised from 10 to 20 mM (48); we
Suppression of Glucagon Secretion 749do not have such information about a-cells. A J-shaped
curve can also be obtained by assuming the opposite, that
K(ATP) conductance saturates first (not shown) because
the directions reverse on the opposite arms of the bell-
shaped curves: When SOC conductance is large, decreasing
K(ATP) conductance decreases secretion, and at low
K(ATP) conductance, decreasing SOC conductance in-
creases secretion. In this case, however, the flattening of
the dose-response curve simulated in Fig. 8 would not occur.
The bell-shaped curves may also help explain the dysre-
gulation of glucagon secretion in both Type-1 and Type-2
diabetes, in which too much glucagon is secreted at high
glucose levels, while not enough glucagon is secreted at
low glucose (49–54). The first effect could be attributed to
diabetic a-cells having a slightly higher K(ATP) channel
conductance. The cell would then sit on the right arm of
the bell-shaped curve, and glucose would stimulate
glucagon secretion rather than suppress it (3,33). A lack
of paracrine insulin to suppress glucagon secretion likely
also plays a role here. Indeed, a chronic deficit in exposure
to insulin could possibly contribute to dysregulation of
a-cell intrinsic mechanisms, such as excessive K(ATP)
expression, in addition to loss of direct control by insulin.
A few other a-cell models have been previously pub-
lished (20,55–57). These models differ quantitatively from
ours, but those of Diderichsen and Go¨pel (20) and of Fri-
dlyand and Philipson (57) also have bell-shaped dose-
response curves, suggesting that this is a robust feature of
a-cells. It should be possible to combine K(ATP) and
SOC effects in those models, if one prefers them, and obtain
results similar to ours.
A major limitation of our model, as well as its predeces-
sors, is that it neglects paracrine effects. We have shown
that, allowing certain assumptions, intrinsic effects are suf-
ficient to account for the key features of the response of
glucagon to glucose, which raises the question of what
role paracrine effects play. We do not deny the importance
of paracrine effects, but suggest that their role is different
than previously proposed: to modulate the core intrinsic
mechanisms and overcome the heterogeneity of the a-cells.
Whereas b-cell heterogeneity is suppressed by gap junc-
tional coupling, a-cells lack this mechanism. A dramatic
indication of this is contained in two recent articles
(41,46), which showed that the majority of a-cells in an islet
increased cytosolic Ca2þ with glucose and only a minority
exhibited decreased Ca2þ. We suggest that insulin and/or so-
matostatin could help suppress a-cells that inappropriately
secrete at high glucose. We believe it is more likely that in-
sulin and somatostatin are important at high glucose than at
low glucose, where their secretion is low. We note as well
that very few a-cells are needed to maintain proper
glucagon secretion (58), so that the surviving minority
would suffice.
Coupling also allows b-cells to secrete synchronously and
generate whole-body pulsatility. Unpublished work by us in-dicates that paracrine effects can serve this function for
a-cells as well. Indeed, at least some a-cells must be active
at high glucose to account for the antisynchronous pulses of
insulin and glucagon observed in elevated glucose
(43,59,60). A full exploration of these issues requires a
model islet with paracrine interactions among a-, b-, and
d-cells. We are currently working on such a model using
the model presented here as a base.SUPPORTING MATERIAL
An Appendix, comprising 20 Model Equations and three tables, is available
at http://www.biophysj.org/biophysj/supplemental/S0006-3495(13)05843-8.
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